Faculty & Staff
Dr. Alok Srivastava
MD, FRACP, FRCPA, FRCP
Professor
Languages
English, Hindi, Tamil, Malayalam, Marathi
- Overview
- Projects
- Publications
- Other Contributions
Dr. Alok Srivastava
Senior Consultant, Department of Clinical Haematology
Head, Haematology Research Unit, St. John’s Research Institute
Dr. Alok Srivastava is an internationally recognized haematologist with over three decades of leadership in bleeding disorders, stem cell transplantation, and gene therapy. After his medical training at Christian Medical College, Vellore, and advanced specialization in Australia, he has gone on to shape haematology practice and research in India and across the Asia‑Pacific region.
At St. John’s, he leads both clinical services and research programs, with a strong focus on hemophilia, bone marrow failure syndromes, and cellular therapies. He has authored hundreds of peer‑reviewed publications in leading journals such as The Lancet, New England Journal of Medicine, Blood, and Haemophilia, and holds multiple patents in gene and cell therapy.
Dr. Srivastava has served in global leadership roles with the World Federation of Hemophilia, International Society on Thrombosis and Haemostasis, and Asia‑Pacific Blood and Marrow Transplantation Group. His contributions have been recognized with prestigious awards including the Inga Marie Nilsson Award (WFH, 2012) and the Esteemed Career Award (ISTH, 2024).
Qualification/ Education
- 1993: Fellowship in Clinical & Laboratory Haematology and Transfusion Medicine (Internal Medicine - Subspeciality Haematology)
Royal Australian College of Physicians - 1993: Fellowship in Haematology (Sub-Speciality)
Royal College of Pathologists of Australasia - 1987: MD in Internal Medicine
Christian Medical College, University of Madras - 1976: MBBS
Christian Medical College, University of Madras
Experience
- Professor & Head, Haematology Research Unit
St. John’s Research Institute, Bengaluru
2024 - Present
Karnataka - Senior Consultant, Clinical Hematology
St. John’s Medical College Hospital, Bengaluru
2024 - Present
Karnataka - Professor, Haematology
Christian Medical College, Vellore
1996 - 2024
Tamil Nadu - Associate Professor, Haematology
Christian Medical College, Vellore
1992 - 1996
Tamil Nadu - Assistant Professor, Haematology
Christian Medical College, Vellore
1987 - 1992
Tamil Nadu
- Professor & Head, Haematology Research Unit
St. John’s Research Institute, Bengaluru
2024 - Present
Karnataka - Senior Consultant, Clinical Hematology
St. John’s Medical College Hospital, Bengaluru
2024 - Present
Karnataka - Professor, Haematology
Christian Medical College, Vellore
1996 - 2024
Tamil Nadu - Associate Professor, Haematology
Christian Medical College, Vellore
1992 - 1996
Tamil Nadu - Assistant Professor, Haematology
Christian Medical College, Vellore
1987 - 1992
Tamil Nadu
No areas of interest specified.
No groups and associations specified.
No project details available.
"Efficacy and safety of fitusiran prophylaxis in people with haemophilia A or haemophilia B with inhibitors (ATLAS-INH): a multicentre, open-label, randomised phase 3 trial"
Guy Young 1, Alok Srivastava 2, Kaan Kavakli 3, Cecil Ross 4, Jameela Sathar 5, Chur-Woo You 6, Huyen Tran 7, Jing Sun 8, Runhui Wu 9, Stacey Poloskey 10, Zhiying Qiu 11, Salim Kichou 12, Shauna Andersson 13, Baisong Mei 13, Savita Rangarajan 14 Lentiviral Gene Therapy with CD34+ Hematopoietic Cells for Hemophilia A
Srivastava A, Abraham A, Aboobacker F, Singh G, Geevar T, Kulkarni U, Selvarajan S, Korula A, Dave RG, Shankar M, Singh AS, Jeba A, Kumaar N, Benjamin C, Lakshmi KM, Srivastava VM, Shaji RV, Nair SC, Brown HC, Denning G, Lollar P, Doering CB, Spencer T. Evaluation of safety and efficacy of multiple intravenous and intraosseous doses of foetal liver-derived mesenchymal stem cells in children with severe osteogenesis imperfecta : the BOOST2B clinical trial protocol
Madhuri V, Ramesh S, Goos A, Paul TV, Nidugala Kesava S, Mathews V, Walther-Jallow L, Götherström C; BOOST2B Study Group; Ekblad Å, Kumar V, Ganesh S, Loganathan L, Raymond R, Kumar A, Daniel D, Thomas N, James D, Kandagaddala M, Mammen P, B A, Srivastava A. Challenges in Global Access to CAR-T cells: an Asian Perspective.
William Yk Hwang, Satoshi Takahashi, Bryan Choi, He Huang, Shin Kawamata, Soo Chin Ng, Pawan Gupta, Amir Ali Hamidieh, Chaiyong Koaykul, Cospiahadi Irawan, Alok Srivastava. Fitusiran prophylaxis in people with severe haemophilia A or haemophilia B without inhibitors (ATLAS-A/B): a multicentre, open-label, randomised, phase 3 trial
Srivastava A, Rangarajan S, Kavakli K, Klamroth R, Kenet G, Khoo L, You CW, Xu W, Malan N, Frenzel L, Bagot CN, Stasyshyn O, Chang CY, Poloskey S, Qiu Z, Andersson S, Mei B, Pipe SW. No Others Contributions details available.